Meeting
2023 ASCO Genitourinary Cancers Symposium
Ability of STAR-CAP staging system to prognosticate risk of subsequent therapies after initial treatment of M0 prostate cancer.
Authors
Daeun Sung
Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT
Daeun Sung , Jonathan David Tward
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Diagnostics and Imaging
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 310)
DOI
10.1200/JCO.2023.41.6_suppl.310
Abstract #
310
Poster Bd #
K10
Abstract Disclosures
Similar Posters
Poster
2020 Genitourinary Cancers Symposium
Health care team and treatment decision-making experiences among prostate cancer patients.
First Author: Nicole E. Nicksic
Poster
2024 ASCO Annual Meeting
The effect of sodium glucose cotransporter-2 inhibitors on mortality and cardiovascular outcomes of patients with prostate cancer receiving luteinizing hormone releasing hormone agonists.
First Author: Zhiting Tang
Poster
2024 ASCO Genitourinary Cancers Symposium
Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer.
First Author: Kassem S Faraj
Poster
2024 ASCO Genitourinary Cancers Symposium
Systemic and tumor-directed therapy for oligometastatic prostate cancer (SOLAR): A phase II trial for veterans with de novo oligometastatic prostate cancer.
First Author: Nicholas George Nickols